About: Duration of seropositivity following yellow fever vaccination in U.S. military service members

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Duration of seropositivity following yellow fever vaccination in U.S. military service members Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 22 November 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu en payares de 2020 (ast) scientific article published on 22 November 2020 (en) 2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 22ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް (dv) наукова стаття, опублікована 22 листопада 2020 (uk)
publication date	wds:Q102387839-CBE0ECD4-FF21-46AD-B860-20C85EE8D68A
publication date	2020-11-22 00:00:00Z (xsd:dateTime)
cites work	wds:Q102387839-10F4AEA9-718F-4864-8E16-55A651F3E88C wds:Q102387839-35DC061A-7C25-4583-A335-8D14C3B0670E wds:Q102387839-36F8C7DE-6D78-49DE-85BD-4B7D360148CC wds:Q102387839-4C4CE659-F46F-4F72-8697-1C2EBA2EF966 wds:Q102387839-4CDF158C-F12E-482F-B250-AF43512F8061 wds:Q102387839-60374F79-DBCD-4790-9614-5FAE17EFB0CC wds:Q102387839-6F1CBC01-A782-4FD6-847E-50F4549580C5 wds:Q102387839-71668E75-638C-44B8-9787-0B8CD8CB3E65 wds:Q102387839-751EC18E-9453-4ECF-BDA4-D8F65A76FBC3 wds:Q102387839-79635EF6-B4C5-4015-A708-C23FC8CDB070 wds:Q102387839-837344E5-4A44-4879-A4E0-CCB63E5185C6 wds:Q102387839-901BEB84-1F1D-42AB-91D3-ED40672CC6C5 wds:Q102387839-97138A2E-9C1E-42C5-A1DB-08EAFF5DD518 wds:Q102387839-9DC1BE15-D20A-47EE-9996-E52C9FE001E8 wds:Q102387839-A47419E0-8E19-4EF5-8320-1F766CD94D0A wds:Q102387839-A4A33AE3-7F64-464E-B642-8FCF46B80E0A wds:Q102387839-A510338E-F1ED-48E2-AA2E-05FCF647EF36 wds:Q102387839-C3B6D3C3-247C-4641-B67E-0FED37C0D195 wds:Q102387839-C575604D-CF2D-458F-AFF9-2D372DF9A0CC wds:Q102387839-D34A1C4A-5FF0-49D3-98B1-BC90315F4D21 wds:Q102387839-D47FE0B4-E1E4-4A55-8578-10A34F49BE05 wds:Q102387839-D9228E7C-A565-4279-BA0F-E62440C077F4 wds:Q102387839-DC79BFCB-6BF8-46A0-A831-A9F4FDC8EC4C wds:Q102387839-EB3E7622-E680-435C-B0ED-6C9BF30161EA wds:Q102387839-EB92C891-E92E-4684-A067-990F41C5B0EB wds:Q102387839-F4CA71F5-EA55-485E-88B1-5BEAA005D157
cites work	Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA. Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: a randomized trial Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus Comparing vaccines: a systematic review of the use of the non-inferiority margin in vaccine trials Yellow fever outbreak in Brazil, 2017. Duration of post-vaccination immunity against yellow fever in adults Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali Detection of anti-yellow fever virus immunoglobulin m antibodies at 3-4 years following yellow fever vaccination Challenges in the Design and Interpretation of Noninferiority Trials. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Preliminary Report. Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among U.S. travelers Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study Duration of post-vaccination humoral immunity against yellow fever in children Long-Term Protection After Fractional-Dose Yellow Fever Vaccination: Follow-up Study of a Randomized, Controlled, Noninferiority Trial Prevalence and titers of yellow fever virus neutralizing antibodies in previously vaccinated adults Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children 17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
author name string	wds:Q102387839-0A474037-41E9-432A-802B-D37B486E3E80 wds:Q102387839-152B31DC-C36D-4AA4-8370-A66966E00885 wds:Q102387839-AA6E20E0-191A-41E7-880E-3033A49F32E9 wds:Q102387839-BCE3BDB2-E625-4146-9121-EABB93AE7EEB wds:Q102387839-E58E9033-7964-4966-A46A-57DEF03982AB
author name string	Christopher A Myers Gary Brice Ewell M Hollis Kelly Fitzpatrick Lori Perry
rdfs:label	Duration of seropositivity following yellow fever vaccination in U.S. military service members (dv) Duration of seropositivity following yellow fever vaccination in U.S. military service members (en) Duration of seropositivity following yellow fever vaccination in U.S. military service members (nl)
skos:prefLabel	Duration of seropositivity following yellow fever vaccination in U.S. military service members (dv) Duration of seropositivity following yellow fever vaccination in U.S. military service members (en) Duration of seropositivity following yellow fever vaccination in U.S. military service members (nl)
name	Duration of seropositivity following yellow fever vaccination in U.S. military service members (dv) Duration of seropositivity following yellow fever vaccination in U.S. military service members (en) Duration of seropositivity following yellow fever vaccination in U.S. military service members (nl)
author	wds:Q102387839-11BB48C4-1BDC-42BE-8290-B60D344649B0 wds:Q102387839-2662847C-FBB0-415E-8C90-21D3CAD8A07C wds:Q102387839-3DD89422-4BC7-40DA-9430-424A2DCA8ACB wds:Q102387839-5E1D4B7D-2AC4-4E37-A1AC-D0EA957C8DB5 wds:Q102387839-CFCB7165-DCC8-494D-964B-EC151F041A42 wds:Q102387839-DF38F5BE-A676-4534-82D3-4DE88C476ED6 wds:Q102387839-E7950832-9E91-4B3D-AA8C-E6A98176D2A1
author	J. Erin Staples Marc Fischer Nicole P Lindsey Brad J Biggerstaff Olga Kosoy Janeen Laven Tabitha Woolpert
title	wds:Q102387839-6BF45180-911F-4485-B50C-8F68EDF7FBFF
title	Duration of seropositivity following yellow fever vaccination in U.S. military service members (en)
instance of	wds:Q102387839-E75B4363-B7E1-4639-BB83-32E37BE8A777
instance of	scholarly article
main subject	wds:Q102387839-1E4C9DEC-424F-4427-B37F-F8A63234F018
main subject	yellow fever

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software